SCHEMBL31475657

SCHEMBL31475657

Nc1cc(C(F)(F)F)nc2c1CCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 16/20 0.42
MEN1 O00255 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
BPTF Q12830 1/20 0.42
CYP2C19 P33261 1/20 0.42
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
GRIN1 Q05586 8/20 0.40
GRIN2A Q12879 8/20 0.40
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
CHRM1 P11229 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40
GRIN3A Q8TCU5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21963366 1.00 ACHE (0.42) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL24978430 0.82 CYP2C19 (0.48) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL22020717 0.80 NOS3 (0.50) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL28617032 0.75 KDM4E (0.40) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL21963370 0.75 ACHE (0.39) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL30162186 0.75 ACHE (0.39) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL28625362 0.72 ALDH1A1 (0.36) ACHEMEN1KMT2AGRIN1GRIN2A
SCHEMBL21963078 0.72 NOS3 (0.53) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL31475655 0.72 NOS3 (0.53) ACHEMEN1MAPK1KMT2ABPTF
SCHEMBL31475651 0.71 ACHE (0.42) ACHEMEN1MAPK1KMT2ABPTF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166065-B Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2025-04-15 CN disclosed